The human papillomavirus (HPV) vaccine, approved in 2006, protects against strains of the virus responsible for 70% of …
GlaxoSmithKline
Rising Pulmonary Disease Cases Among Smokers Spurs New Drug Company Rivalry
Drugmakers go head-to-head with new treatments
Top 10 Drug Company Settlements
Multibillion-dollar settlements against big drug companies have become all too common in recent years. Here’s a rogues gallery of the worst offenders
Breaking Down GlaxoSmithKline’s Billion-Dollar Wrongdoing
What the drug company did to promote Paxil, Wellbutrin and Avandia illegally — and what it meant for patients
New Melanoma Drugs Beat Chemotherapy in Trials
In two large-scale trials, new drugs made by GlaxoSmithKline extended the lives of patients with advanced melanoma longer than standard chemotherapy.
Early Results: A First-Ever Malaria Vaccine Protects Children
A first-ever malaria vaccine tested in children in sub-Saharan Africa cut the risk of infection with malaria by about half, researchers announced in a teleconference on Tuesday.
Man Claims Parkinson’s Drug Turned Him Into a Gay Sex Addict
Didier Jambart, 51, of Nantes, France, began taking GlaxoSmithKline’s drug Requip (ropinirole) in 2003 to treat symptoms of Parkinson’s disease. Soon after, the married father of two began exhibiting strange, uncharacteristic …
FDA panel in favor of keeping Avandia on the market
Despite concerns that the popular GlaxoSmithKline diabetes drug Avandia could raise the risk for heart attack, a Food and Drug Administration (FDA) advisory panel voted today in favor of keeping the medication on the market. As the Wall Street Journal reports, 20 members of the 33-person panel voted in favor of keeping Avandia on the
…
Glaxo to make zinc-free denture cream
In light of recent stories of zinc-poisoning among users of several denture creams, and a subsequent wave of lawsuits, pharmaceutical giant GlaxoSmithKline, the producer of Poligrip products, announced that it will remove zinc from its denture creams, the Associated Press reports. In the meantime, Glaxo issued a press release emphasizing
…